it’s oncology, not what they do. Vifor at least has some strategic overlap because kidney disease patients periodically go to clinics for treatment, like PID/CIDP patients that get immunoglobulin
it’s oncology, not what they do. Vifor at least has some...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$311.22 |
Change
0.100(0.03%) |
Mkt cap ! $149.4B | |||
| Open | High | Low | Value | Volume |
| $308.37 | $311.65 | $307.33 | $342.1M | 1.151M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 591 | $342.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $280.10 | 1685 | 4 |
View Market Depth
| Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |